Examples of 'studied in patients with severe' in a sentence
Meaning of "studied in patients with severe"
Studied in patients with severe: Indicates research or investigation conducted on individuals diagnosed with severe medical conditions
How to use "studied in patients with severe" in a sentence
Basic
Advanced
studied in patients with severe
Pembrolizumab has not been studied in patients with severe renal impairment.
The pharmacokinetics of micafungin has not been studied in patients with severe hepatic insufficiency.
Nerlynx has not been studied in patients with severe renal impairment including patients on dialysis.
The pharmacokinetics of encorafenib have not been studied in patients with severe renal impairment.
BYETTA has not been studied in patients with severe gastrointestinal disease, including gastroparesis.
Zaleplon has not been adequately studied in patients with severe renal impairment.
HALAVEN was not studied in patients with severe hepatic impairment Child-Pugh C.
Trastuzumab emtansine has not been studied in patients with severe hepatic impairment.
Repatha has not been studied in patients with severe hepatic impairment ( Child-Pugh class C ) see section 4.4.
Macugen has not been adequately studied in patients with severe renal impairment.
Januvia has not been studied in patients with severe hepatic insufficiency.
The pharmacokinetics of alectinib has not been studied in patients with severe renal impairment.
Edarbi has not been studied in patients with severe hepatic impairment.
The use of baricitinib has not been studied in patients with severe hepatic impairment.
VFEND has not been studied in patients with severe chronic hepatic cirrhosis Child-Pugh C.
The safety of BLINCYTO has not been studied in patients with severe renal impairment.
Exenatide has not been studied in patients with severe gastrointestinal disease, including gastroparesis.
The PK of gemtuzumab ozogamicin has not been studied in patients with severe renal impairment.
TESAVEL has not been studied in patients with severe hepatic insufficiency.
Rilpivirine hydrochloride has not been studied in patients with severe hepatic impairment CPT Score C.
SUTENT has not been studied in patients with severe kidney or severe liver problems.
Dextromethorphan / quinidine has not been studied in patients with severe renal impairment.
Onpattro has not been studied in patients with severe renal impairment or end-stage renal disease.
Renal Insufficiency, ELOXATIN has not been studied in patients with severe renal impairment.
Eviplera has not been studied in patients with severe hepatic impairment CPT Score C.
Trastuzumab emtansine was not studied in patients with severe hepatic impairment.
Rilpivirine has not been studied in patients with severe hepatic impairment Child-Pugh Class C.
The pharmacokinetics of lumiracoxib have not been studied in patients with severe hepatic impairment Child-Pugh > 9.
EDURANT has not been studied in patients with severe hepatic impairment Child-Pugh score C.
Tolvaptan has not been studied in patients with severe renal failure.
Revestive has not been studied in patients with severe hepatic impairment see sections 4.4 and 5.2.
Paliperidone has not been studied in patients with severe hepatic impairment.
Cresemba has not been studied in patients with severe hepatic impairment Child-Pugh Class C.
Valaciclovir has not been studied in patients with severe immune deficiency.
Spravato has not been studied in patients with severe hepatic impairment ( Child-Pugh class C ).
This medicinal product has not been studied in patients with severe ( Child Pugh C ) hepatic impairment.
Cobicistat has not been studied in patients with severe hepatic impairment Child-Pugh Class C.
The pharmacokinetics of Varuby was not studied in patients with severe hepatic impairment ( Child-Pugh Class C ).
Mirabegron has not been studied in patients with severe hepatic impairment Child-Pugh Class C.
Ipreziv has not been studied in patients with severe hepatic impairment.
Naloxegol has not been studied in patients with severe hepatic impairment.
Revestive has not been studied in patients with severe hepatic impairment.
Remodulin has not been studied in patients with severe liver dysfunction.
Alecensa has not been studied in patients with severe renal impairment.
Famciclovir has not been studied in patients with severe hepatic impairment.
Naldemedine has not been studied in patients with severe hepatic impairment.
Emicizumab has not been studied in patients with severe renal or hepatic impairment.
KALETRA has not been studied in patients with severe hepatic impairment.
MYLOTARG has not been studied in patients with severe renal impairment.
Trastuzumab emtansine has not been studied in patients with severe hepatic impairment Child-Pugh class C.
You'll also be interested in:
Examples of using Severe
Show more
This place has a severe tonal problem
Severe thermal burns can occur on contact
There are mild and severe cases of frostbite
Examples of using Patients
Show more
Patients at the very heart of our mission
We have the best patients in the world
Patients also pay for essential drugs
Examples of using Studied
Show more
This subject is studied for five years
Studied all about you quiet guys
It has not been studied in these age groups
